Characterization of a human cytomegalovirus with phosphorylation site mutations in the immediate-early 2 protein

Journal of Virology

Volumn 76, Issue 2, 2002, Pages 928-932

  Heider, J A ^a   Yu, Y ^a   Shenk, T ^a   Alwine, J C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN 2; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; FIBROBLAST; GENE ACTIVATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SIMIAN VIRUS 40; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION; VIROGENESIS; VIRUS INFECTION; VIRUS MUTANT; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; CYTOMEGALOVIRUS; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HUMANS; IMMEDIATE-EARLY PROTEINS; KINETICS; MEMBRANE GLYCOPROTEINS; MUTATION; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RNA, VIRAL; SIMIAN VIRUS 40; SUMO-1 PROTEIN; TRANS-ACTIVATORS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0036140217     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.2.928-932.2002     Document Type: Article

References (37)

1. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9
2. Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle
3. 1 checkpoint function
4. The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein
5. Role of human cytomegalovirus immediate-early proteins in cell growth control
6. Human cytomegalovirus immediate-early 2 (IE2) protein can transactivate the human hsp70 promoter by alleviation of Dr1-mediated repression
7. Activation of transcription of the human cytomegalovirus early UL4 promoter by the Ets transcription factor binding element
8. SUMO-1 modification of IκBα inhibits NF-κB activation
9. The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID
10. The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently transactivate the c-fos, c-myc and hsp70 promoters via basal promoter elements
11. Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2
12. Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter
13. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b
14. A human cytomegalovirus early promoter with upstream negative and positive cis-acting elements: IE2 negates the effect of the negative element, and NF-Y binds to the positive element
15. Binding of cellular repressor protein or the IE2 protein to a cis-acting negative regulatory element upstream of a human cytomegalovirus early promoter
16. Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products
17. In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins
18. Effects of human cytomegalovirus major immediate-early proteins in controlling the cell cycle and inhibiting apoptosis: Studies with ts13 cells
19. TAF-like functions of human cytomegalovirus immediate-early proteins
20. Transcriptional activation by the human cytomegalovirus immediate-early proteins: Requirements for simple promoter structures and interactions with multiple components of the transcription complex
21. An in vitro system for human cytomegalovirus immediate early 2 protein (IE2)-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate early promoter
22. Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: Mutational analysis of the viral proteins
23. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes
24. The immediate early genes of human cytomegalovirus upregulate expression of the cellular genes myc and fos
25. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption
26. The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells
27. The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site
28. 1 into early S phase in terminally differentiated cells
29. Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus
30. Identification of sequence requirements and trans-acting functions necessary for regulated expression of a human cytomegalovirus early gene
31. Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2
32. Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains
33. 1
34. The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation
35. The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor β1 gene through an Egr-1 binding site
36. Human cytomegalovirus upregulates NF-κ B activity by transactivating the NF-κB p105/p50 and p65 promoters
37. Human cytomegalovirus IE1 and IE2 proteins block apoptosis